MeSH tree: D23.050.301.290
A dual-threshold model for measuring the pancreatic tumor marker serum carbohydrate antigen 19-9 (CA19-9) identified patients with pancreatic cancer who had high-risk disease despite having low CA19-9 levels because of a ...
4 hours ago
0
1
Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The device identifies the biomarker molecule CA19-9, which is associated with the disease, at low concentrations ...
Apr 22, 2026
0
5
A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced the detection of pancreatic ductal adenocarcinoma (PDAC) compared to measuring ...
Jan 28, 2026
0
11
Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic tools. While the traditional staging systems, such as the TNM classification, focus on anatomical ...
Dec 13, 2025
0
13
Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to responses in more than a third of patients with neuregulin 1 (NRG1)-positive cholangiocarcinoma, ...
Oct 22, 2025
0
15
A French woman from the Caribbean island of Guadeloupe has been identified as the only known carrier of a new blood type, dubbed "Gwada negative," France's blood supply agency has announced.
Jun 22, 2025
0
167
Researchers at Cleveland Clinic and Case Western Reserve University (CWRU) have developed a new method that could potentially help provide better access to lung transplant for transplant candidates who are hard to match because ...
Oct 15, 2024
0
17
An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with the biomarker CA 19-9, according to research presented at the American Association for Cancer Research ...
Apr 8, 2024
0
55
A blood test appears capable of detecting early-stage pancreatic cancers with up to 97% accuracy, a new study reports.
Apr 8, 2024
0
56
The first study to look at the prevalence of lesser-known blood groups within the Australian population that need to be "matched" during a blood transfusion shows they have changed, most likely due to increasing ethnic diversity.
Mar 5, 2024
0
28
